Dr. Maini is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1625 SE 3rd Ave Ste 525
Fort Lauderdale, FL 33316Phone+1 954-355-4975Fax+1 954-355-5898
Education & Training
- Zucker School of Medicine at Hofstra/Northwell at Lenox Hill HospitalFellowship, Hematology and Medical Oncology, 1998 - 2001
- Icahn School of Medicine at Mount Sinai/Morningside/WestResidency, Internal Medicine, 1995 - 1998
- Lady Hardinge Medical CollegeClass of 1987
Certifications & Licensure
- FL State Medical License 1999 - 2025
- NY State Medical License 2001 - 2025
- GA State Medical License 1998 - 2001
- NJ State Medical License 2000 - 2001
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Hospice and Palliative Medicine
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- S1201: Combination Chemo for Patients W/Advanced or Metastatic Esophageal, Gastric, or Gastroesophageal Junction Cancer Start of enrollment: 2012 Feb 01
- PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score Start of enrollment: 2012 May 01
- S1216, Phase III ADT+TAK-700 vs. ADT+Bicalutamide for Metastatic Prostate Cancer Start of enrollment: 2013 Mar 08
Publications & Presentations
PubMed
- 59 citationsBarriers to the Access and Use of Rituximab in Patients with Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia: A Physician Survey.William H. Baer Ii, Archana Maini, Ira Jacobs
Pharmaceuticals. 2014-05-07 - 4 citationsHb Jeddah [α68(E17)Asn→His (α1)]: A Newly Recognized α Chain Variant, Seen in Combination with Hb S [β6(A3)Glu→Val], and Found in Three Separate Families of Middle Eas...Karra M. Markley, Mohamed Elkhalifa, Archana Maini, James D. Hoyer
Hemoglobin. 2008-01-01 - 3 citationsRegression of grade III astrocytoma during the treatment of CML with imatinib mesylate.Suriya Jayawardena, Danushan Sooriabalan, Shalaka Indulkar, Hyun Ho Kim, Abu Matin
American Journal of Therapeutics. 2006-09-01
Journal Articles
- Clinical Remission of Primary Aggressive CD8 + Cutaneous T-Cell Lymphoma After Pralatrexate InfusionFrancisco A. Kerdel, MD; Andrew Richard Styperek, MD, MBA; Archana Maini, MD, JAMA Dermatol, 1/1/2014
- Surgical Coronary Revascularization in Geriatric PatientsValavanur A. Subramaniam, Nilesh Patel, Archana Maini, The American Journal of Geriatric Cardiology, 1/1/2002
- Barriers to the Access and Use of Rituximab in Patients with Non-Hodgkin’s Lymphoma and Chronic Lymphocytic Leukemia: A Physician SurveyWilliam H. Baer II , Archana Maini, Ira Jacobs, Pharmaceuticals, 1/29/2014
Abstracts/Posters
- Recurrence of a Rare Carotid Body Tumor: A Case ReportCielo Z. Rose, DO; Leonard Dunikoski; Archana Maini, MD, Resident Poster competition, Broward Health, 1/1/2014
- Variables Defining Severity of Sickle Cell Disease: A Single Institution ExperienceMaini A, Hasan S, Leneweaver K, Howard J, Bercovici N, National Sickle Cell Disease Scientific Meeting, Miami, FL, 1/1/2013
- Diffuse Large B cell Lymphoma Mimicking Advanced Basal Cell CarcinomaEmmanuel Akinyemi, MD; Le Mai, MD; Abu Martin, MD; Anomadarshi Barua, MD; Archana Maini, MD, Journal of National Medical Association, 1/1/2007
- Join now to see all
Lectures
- Different cancers including breast cancer in colored women and multiple myeloma with cancer survivorsFort Lauderdale, FL - 1/1/2010
- Sickle Cell AnemiaCIH - 1/1/2004
- Splenic SarcoidosisCIH - 1/1/2004
- Join now to see all
Other
- Breast CancerMaini A, South Florida Hospital News publication
1/1/2013 - Stage Zero Breast CancerMaini A, WPLG local Chanel 10
1/1/2013 - Adult Sickle Cell Day UnitMaini A, WHQT-FM
1/1/2013 - Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: